
Target price is 3.18/423.60% or more.
Vermillion, Inc.
Building III
Suite 100 12117 Bee Caves Road
Austin, TX 78738
United States
512-519-0400
http://www.vermillion.com
Sector: Healthcare
Industry: Diagnostics & Research
Full Time Employees: 52
Vermillion, Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women in the United States. The company’s diagnostic tests include OVA1, a blood test for the pre-surgical identification of women who are at high risk of having a malignant ovarian tumor; and Overa, a multivariate index assay second generation test to determine the malignancy of ovarian cancer in women. It also offers in-vitro diagnostic (IVD) trial services to third-party customers; and laboratory services to meet the needs of IVD manufacturers to commercialize high-complexity assays. The company serves clinical reference laboratories, hospital laboratories, and physician offices. Vermillion, Inc. was founded in 1993 and is headquartered in Austin, Texas.
Target price is 3.18/423.60% or more.